Advertorial B. Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. SAHJ [Internet]. 2017Mar.20 [cited 2025Oct.8];13(1):42-3. Available from: https://www.journals.ac.za/SAHJ/article/view/1694